The novel antibody therapies market for advanced stage drugs is anticipated to grow at a CAGR of 36%
Owing to the recent approval of therapies, such as Elzonris®, Pluvicto®, there has been a substantial increase in the R&D activity to evaluate the use of novel antibody therapy candidates for the treatment of a variety of disease indications.
https://www.rootsanalysis....
Owing to the recent approval of therapies, such as Elzonris®, Pluvicto®, there has been a substantial increase in the R&D activity to evaluate the use of novel antibody therapy candidates for the treatment of a variety of disease indications.
https://www.rootsanalysis....
28.09.2022
Только люди, упомянутые в этом сообщении пользователем jameshebrew, могут отвечать
